CFTR with a partially deleted R domain and uses thereof
US7339046B2 · kind B2 · utility
2Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 14, 2003 |
| Grant date | Mar 4, 2008 |
| Priority date | — |
| Expiry date | Aug 29, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/4712
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention offers new therapies for treating Cystic Fibrosis (CF), that are based on novel DNA molecules and proteins encoded by the DNA molecules. The present invention features DNA molecules encoding CFTR having a partially deleted R domain. The partial deletions in the R domain are between residues 708 and 835 of the wild-type CFTR.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.